IT1255461B - Eteri di imidazoli ad attivita' a ii antagonista - Google Patents

Eteri di imidazoli ad attivita' a ii antagonista

Info

Publication number
IT1255461B
IT1255461B ITMI921832A ITMI921832A IT1255461B IT 1255461 B IT1255461 B IT 1255461B IT MI921832 A ITMI921832 A IT MI921832A IT MI921832 A ITMI921832 A IT MI921832A IT 1255461 B IT1255461 B IT 1255461B
Authority
IT
Italy
Prior art keywords
imidazoli
antagonist
ethers
activated
compounds
Prior art date
Application number
ITMI921832A
Other languages
English (en)
Inventor
Aldo Salimbeni
Jacques Mizrahi
Carlo Scolastico
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Priority to ITMI921832A priority Critical patent/IT1255461B/it
Publication of ITMI921832A0 publication Critical patent/ITMI921832A0/it
Priority to EP93915957A priority patent/EP0652869B1/en
Priority to PCT/EP1993/001909 priority patent/WO1994002467A1/en
Priority to US08/374,696 priority patent/US5538987A/en
Priority to AU45709/93A priority patent/AU4570993A/en
Priority to DE69309280T priority patent/DE69309280T2/de
Publication of ITMI921832A1 publication Critical patent/ITMI921832A1/it
Application granted granted Critical
Publication of IT1255461B publication Critical patent/IT1255461B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

Sono descritti composti di formula generale (FORMULA I) dei procedimenti per la loro preparazione e loro uso come agenti terapeutici.I composti descritti sono dotati di proprietà A II antagoniste e quindi utilizzabili in varie patologie cardiovascolari.
ITMI921832A 1992-07-28 1992-07-28 Eteri di imidazoli ad attivita' a ii antagonista IT1255461B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921832A IT1255461B (it) 1992-07-28 1992-07-28 Eteri di imidazoli ad attivita' a ii antagonista
EP93915957A EP0652869B1 (en) 1992-07-28 1993-07-20 Imidazole ethers having a ii antagonist activity
PCT/EP1993/001909 WO1994002467A1 (en) 1992-07-28 1993-07-20 Imidazole ethers having a ii antagonist activity
US08/374,696 US5538987A (en) 1992-07-28 1993-07-20 Imidazole ethers having a II antagonist activity
AU45709/93A AU4570993A (en) 1992-07-28 1993-07-20 Imidazole ethers having a ii antagonist activity
DE69309280T DE69309280T2 (de) 1992-07-28 1993-07-20 Imidazoläther mit a ii antagonistischer wirkung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921832A IT1255461B (it) 1992-07-28 1992-07-28 Eteri di imidazoli ad attivita' a ii antagonista

Publications (3)

Publication Number Publication Date
ITMI921832A0 ITMI921832A0 (it) 1992-07-28
ITMI921832A1 ITMI921832A1 (it) 1994-01-28
IT1255461B true IT1255461B (it) 1995-11-02

Family

ID=11363761

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921832A IT1255461B (it) 1992-07-28 1992-07-28 Eteri di imidazoli ad attivita' a ii antagonista

Country Status (6)

Country Link
US (1) US5538987A (it)
EP (1) EP0652869B1 (it)
AU (1) AU4570993A (it)
DE (1) DE69309280T2 (it)
IT (1) IT1255461B (it)
WO (1) WO1994002467A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213934D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Chemical compounds
AU716123B2 (en) * 1996-04-03 2000-02-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6080870A (en) * 1996-04-03 2000-06-27 Merck & Co., Inc. Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6063930A (en) * 1996-04-03 2000-05-16 Merck & Co., Inc. Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
DE19713608A1 (de) * 1997-04-02 1998-10-08 Braun Ag Meßspitze für Strahlungsthermometer
CN101085772A (zh) * 2006-06-07 2007-12-12 上海艾力斯医药科技有限公司 一类具有PPARγ激动剂活性的化合物及其应用
CN101260103A (zh) * 2007-03-09 2008-09-10 上海艾力斯医药科技有限公司 一类具有部分PPARγ激动剂活性的化合物及其应用
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN105017226A (zh) * 2015-06-29 2015-11-04 千辉药业（安徽）有限责任公司 一种三苯甲基洛沙坦的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
IL98319A (en) * 1990-07-05 1997-04-15 Roussel Uclaf Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
US5187271A (en) * 1991-02-28 1993-02-16 G. D. Searle & Co. N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
GB9121463D0 (en) * 1991-10-10 1991-11-27 Smithkline Beecham Corp Medicament
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
ITMI921832A1 (it) 1994-01-28
DE69309280T2 (de) 1997-07-10
DE69309280D1 (de) 1997-04-30
EP0652869B1 (en) 1997-03-26
WO1994002467A1 (en) 1994-02-03
US5538987A (en) 1996-07-23
ITMI921832A0 (it) 1992-07-28
AU4570993A (en) 1994-02-14
EP0652869A1 (en) 1995-05-17

Similar Documents

Publication Publication Date Title
GB9514473D0 (en) Chemical compounds
NZ514711A (en) Compounds useful as anti-inflammatory agents
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
DE69925133D1 (de) Pyrrolobenzodiazepine
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
AU2002213421A1 (en) Condensed pyridoindole derivatives
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
ATE228364T1 (de) Indolalkaloide als antientzündliche wirkstoffe
MX9800483A (es) Derivados de piperazina y su uso como antagonistas de 5-ht1a.
IT1255461B (it) Eteri di imidazoli ad attivita' a ii antagonista
AU2002213419A1 (en) Condensed pyridoindole derivatives
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DE69330601D1 (de) Serotoninergische ergolin derivate
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
HU912594D0 (en) Solid, orally usable forms containing iphosphamide as active agents
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
CA2423357A1 (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors
CA2445620A1 (en) Tetracyclic compounds as pde5-inhibitors
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
DE3268605D1 (en) 3,7a-diazacyclohepta(j,k)fluorene derivatives, their preparation and therapeutical use
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960725